Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.3.0.814
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Statements of Operations [Abstract]        
Revenue
Operating expenses:        
Research and development, net of reimbursements $ 2,828,093 $ 4,141,390 $ 10,714,766 $ 7,861,790
General and administrative 1,794,901 2,889,195 9,151,667 7,722,380
Depreciation expense 16,820 14,326 43,409 23,783
Total operating expenses 4,639,814 7,044,911 19,909,842 15,607,953
Loss from operations (4,639,814) $ (7,044,911) (19,909,842) $ (15,607,953)
Other income (expense):        
Interest expense (588) (7,868)
Gain (loss) on change in fair value of derivative liabilities 694,208 $ 967,887 5,432,918 $ (3,653,473)
Total other income (expense) 693,620 967,887 5,425,050 (3,653,473)
Net loss $ (3,946,194) $ (6,077,024) $ (14,484,792) $ (19,261,426)
Net loss per common share - basic and diluted $ (0.10) $ (0.21) $ (0.39) $ (0.73)
Weighted average common shares outstanding - basic and diluted 41,167,352 28,496,902 37,069,779 26,540,368